Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10426
CALL
Jakks Pacific
JAKK
$294M
| $200K | ﹤0.01% |
7,100
+6,000
| +545% | +$164K |
|
10427
PUT
Liberty Global Class C
LBTYK
$3.49B
| $200K | ﹤0.01% |
15,200
+6,500
| +75% | +$112K |
|
10428
Natural Resource Partners
NRP
$1.39B
| $200K | ﹤0.01% |
1,799
-23,383
| -93% | -$2.41M |
|
|
OTLY
10429
CALL
Oatly Group
OTLY
$441M
| $200K | ﹤0.01% |
15,055
-235
| -2% | -$3.46K |
|
10430
CALL
Innoviva
INVA
$1.53B
| $200K | ﹤0.01% |
11,500
-1,100
| -9% | -$21.1K |
|
10431
OptimizeRx
OPRX
$164M
| $199K | ﹤0.01% |
41,049
-34,729
| -46% | -$194K |
|
10432
PUT
Sasol
SSL
$7.39B
| $199K | ﹤0.01% |
43,700
-114,000
| -72% | -$644K |
|
10433
Arqit Quantum
ARQQ
$424M
| $199K | ﹤0.01% |
+5,127
| New | +$76.1K |
|
10434
CALL
CXApp
CXAI
$12.1M
| $199K | ﹤0.01% |
109,400
+103,400
| +1,723% | +$166K |
|
10435
PUT
ProShares UltraShort Euro
EUO
$33.1M
| $199K | ﹤0.01% |
5,700
-5,100
| -47% | -$167K |
|
10436
PUT
Quanterix
QTRX
$122M
| $199K | ﹤0.01% |
18,700
+12,300
| +192% | +$150K |
|
10437
PUT
Hyster-Yale Materials Handling
HY
$618M
| $199K | ﹤0.01% |
3,900
-1,300
| -25% | -$76K |
|
10438
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.87B
| $199K | ﹤0.01% |
7,109
-10,230
| -59% | -$299K |
|
10439
CALL
Adeia
ADEA
$3.29B
| $199K | ﹤0.01% |
14,200
-6,600
| -32% | -$83.5K |
|
10440
Nuveen California Municipal Value Fund
NCA
$303M
| $198K | ﹤0.01% |
+23,450
| New | +$207K |
|
|
MAGN
10441
PUT
Magnera Corp
MAGN
$444M
| $198K | ﹤0.01% |
10,900
+10,515
| +2,731% | +$215K |
|
|
SEM
10442
CALL
DELISTED
Select Medical
SEM
| $198K | ﹤0.01% |
10,500
+4,004
| +62% | +$77.2K |
|
10443
PUT
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
| $198K | ﹤0.01% |
6,900
+6,700
| +3,350% | +$194K |
|
10444
PUT
Civeo
CVEO
$344M
| $198K | ﹤0.01% |
8,700
+2,100
| +32% | +$52.6K |
|
10445
CALL
Solid Biosciences
SLDB
$986M
| $198K | ﹤0.01% |
49,400
-7,800
| -14% | -$42.8K |
|
|
ONL
10446
Orion Office REIT
ONL
$164M
| $197K | ﹤0.01% |
53,226
-49,276
| -48% | -$194K |
|
10447
PUT
Enerpac Tool Group
EPAC
$1.89B
| $197K | ﹤0.01% |
4,800
+3,900
| +433% | +$179K |
|
10448
CALL
Invesco China Technology ETF
CQQQ
$3.18B
| $197K | ﹤0.01% |
5,000
-1,600
| -24% | -$66.5K |
|
|
TSSI
10449
PUT
TSS Inc
TSSI
$273M
| $197K | ﹤0.01% |
+16,600
| New | +$161K |
|
10450
CALL
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
| $197K | ﹤0.01% |
2,900
-1,400
| -33% | -$99K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.